Insufficient scRNA-seq data for expression of NEIL3 at single-cell level.
Insufficient scRNA-seq data for expression of NEIL3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 95% | 207.65 | 1714 / 1809 | 93% | 4.54 | 437 / 472 |
intestine | 48% | 36.64 | 463 / 966 | 96% | 5.13 | 504 / 527 |
lung | 48% | 21.37 | 276 / 578 | 89% | 6.03 | 1029 / 1155 |
esophagus | 40% | 68.75 | 582 / 1445 | 96% | 6.77 | 176 / 183 |
stomach | 33% | 19.96 | 120 / 359 | 95% | 4.69 | 272 / 286 |
ovary | 8% | 5.18 | 15 / 180 | 97% | 5.05 | 418 / 430 |
breast | 12% | 3.82 | 54 / 459 | 89% | 4.61 | 1000 / 1118 |
lymph node | 0% | 0 | 0 / 0 | 100% | 6.20 | 29 / 29 |
tonsil | 0% | 0 | 0 / 0 | 100% | 10.35 | 45 / 45 |
uterus | 4% | 2.14 | 7 / 170 | 96% | 7.90 | 440 / 459 |
bladder | 5% | 1.43 | 1 / 21 | 88% | 5.24 | 443 / 504 |
spleen | 83% | 50.88 | 200 / 241 | 0% | 0 | 0 / 0 |
pancreas | 4% | 1.09 | 12 / 328 | 68% | 1.59 | 121 / 178 |
liver | 9% | 5.46 | 21 / 226 | 53% | 1.91 | 216 / 406 |
peripheral blood | 60% | 173.39 | 553 / 929 | 0% | 0 | 0 / 0 |
brain | 1% | 0.24 | 22 / 2642 | 50% | 2.52 | 356 / 705 |
adrenal gland | 25% | 7.22 | 64 / 258 | 25% | 0.72 | 58 / 230 |
kidney | 9% | 7.98 | 8 / 89 | 34% | 0.98 | 304 / 901 |
thymus | 8% | 2.25 | 50 / 653 | 19% | 4.47 | 112 / 605 |
prostate | 7% | 1.95 | 16 / 245 | 17% | 0.39 | 87 / 502 |
blood vessel | 20% | 6.17 | 266 / 1335 | 0% | 0 | 0 / 0 |
adipose | 16% | 5.93 | 190 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 15% | 0.25 | 12 / 80 |
heart | 5% | 1.52 | 39 / 861 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.11 | 4 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006285 | Biological process | base-excision repair, AP site formation |
GO_0006284 | Biological process | base-excision repair |
GO_0036297 | Biological process | interstrand cross-link repair |
GO_0045007 | Biological process | depurination |
GO_0005694 | Cellular component | chromosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0003906 | Molecular function | DNA-(apurinic or apyrimidinic site) endonuclease activity |
GO_0003690 | Molecular function | double-stranded DNA binding |
GO_1904931 | Molecular function | MCM complex binding |
GO_0140078 | Molecular function | class I DNA-(apurinic or apyrimidinic site) endonuclease activity |
GO_0019104 | Molecular function | DNA N-glycosylase activity |
GO_0003684 | Molecular function | damaged DNA binding |
GO_0003697 | Molecular function | single-stranded DNA binding |
GO_0000405 | Molecular function | bubble DNA binding |
GO_0008270 | Molecular function | zinc ion binding |
Gene name | NEIL3 |
Protein name | Endonuclease 8-like 3 (EC 3.2.2.-) (EC 4.2.99.18) (DNA glycosylase FPG2) (DNA glycosylase/AP lyase Neil3) (Endonuclease VIII-like 3) (Nei-like protein 3) Nei like DNA glycosylase 3 |
Synonyms | |
Description | FUNCTION: DNA glycosylase which prefers single-stranded DNA (ssDNA), or partially ssDNA structures such as bubble and fork structures, to double-stranded DNA (dsDNA) . Mediates interstrand cross-link repair in response to replication stress: acts by mediating DNA glycosylase activity, cleaving one of the two N-glycosyl bonds comprising the interstrand cross-link, which avoids the formation of a double-strand break but generates an abasic site that is bypassed by translesion synthesis polymerases (By similarity). In vitro, displays strong glycosylase activity towards the hydantoin lesions spiroiminodihydantoin (Sp) and guanidinohydantoin (Gh) in both ssDNA and dsDNA; also recognizes FapyA, FapyG, 5-OHU, 5-OHC, 5-OHMH, Tg and 8-oxoA lesions in ssDNA . No activity on 8-oxoG detected . Also shows weak DNA-(apurinic or apyrimidinic site) lyase activity . In vivo, appears to be the primary enzyme involved in removing Sp and Gh from ssDNA in neonatal tissues . . |
Accessions | ENST00000513321.1 ENST00000264596.4 D6RAV1 Q8TAT5 |